The stock of Nirman Agri Genetics Ltd (Stock ID: 1003819) closed at ₹51.5 on 19 Nov 2025, which is also its new 52-week low. This price represents the lower band of the permitted daily price movement, indicating that the stock was unable to trade below this threshold due to regulatory limits. The maximum permissible price band for the day was ₹5, and the stock moved down by ₹2.7 from its previous close, resulting in a 4.98% decline.
Trading volumes were subdued, with a total traded volume of 0.33 lakh shares and a turnover of ₹0.16995 crore. The limited volume suggests that despite the sharp price fall, the stock did not witness heavy buying interest to absorb the selling pressure. This scenario often points to unfilled supply orders and panic selling, where sellers dominate the market and buyers remain hesitant.
Comparatively, the Other Agricultural Products sector recorded a positive return of 0.85% on the same day, while the Sensex index was nearly flat with a marginal decline of 0.02%. Nirman Agri Genetics’ underperformance by approximately 5.36% relative to its sector highlights the stock-specific challenges it faced on 19 Nov 2025.
Strong fundamentals, solid momentum, fair price – This Large Cap from the NBFC sector checks every box for our Top 1%. This should definitely be on your radar!
- Complete fundamentals package
- Technical momentum confirmed
- Reasonable valuation entry
Further technical analysis reveals that Nirman Agri Genetics is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This consistent positioning below short- and long-term averages signals a bearish trend and suggests that the stock has been under pressure for an extended period.
Investor participation has also declined markedly. The delivery volume on 18 Nov 2025 was 48,300 shares, which is down by 66.79% compared to the five-day average delivery volume. This drop in delivery volume indicates that fewer investors are holding the stock for the long term, possibly reflecting a lack of confidence or increased risk aversion among shareholders.
Liquidity metrics show that the stock remains sufficiently liquid for small trade sizes, with a traded value representing about 2% of the five-day average traded value. This liquidity level allows for trades up to ₹0.01 crore without significant market impact, but the low volumes on the day of the circuit hit suggest that larger trades may face challenges in execution.
Nirman Agri Genetics operates within the Other Agricultural Products industry and holds a micro-cap market capitalisation of approximately ₹43 crore. The company’s Mojo Score stands at 37.0, with a recent adjustment in its evaluation reflected by a change in its Mojo Grade from Hold to Sell on 17 Nov 2025. This revision aligns with the observed price weakness and market sentiment.
Why settle for Nirman Agri Genetics ? SwitchER evaluates this Other Agricultural Products micro-cap against peers, other sectors, and market caps to find you superior investment opportunities!
- Comprehensive evaluation done
- Superior opportunities identified
- Smart switching enabled
The sharp decline and lower circuit hit on 19 Nov 2025 can be attributed to a combination of factors including heavy selling pressure, unfilled supply orders, and a lack of buyer interest. Panic selling often exacerbates such moves, as investors rush to exit positions amid uncertainty or negative sentiment. The stock’s inability to trade below ₹51.5 despite strong downward momentum indicates regulatory safeguards to prevent excessive volatility.
For investors and market participants, the current scenario suggests caution. The stock’s performance relative to its sector and the broader market, combined with technical indicators and declining delivery volumes, points to a challenging environment for Nirman Agri Genetics in the near term. Monitoring further developments, including volume trends and price action around key support levels, will be essential for assessing potential recovery or continued weakness.
In summary, Nirman Agri Genetics’ stock hitting the lower circuit limit on 19 Nov 2025 reflects significant market stress characterised by maximum daily loss of 4.98%, subdued liquidity, and falling investor participation. While the broader sector and market indices showed resilience, this micro-cap stock faced distinct pressures that led to its underperformance and regulatory price band enforcement.
Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →
